文献速递糖尿病

HbA1c与更新版葡萄糖管理指标(uGMI)与1型糖尿病成人新发糖尿病视网膜病变的关联:纵向研究

Association of HbA1c and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study.
PubMed 文献 · Diabetologia · 2025-11-11

本研究基于既往发表的纵向病例对照研究,纳入1型糖尿病成人受试者诊断新发糖尿病视网膜病变前最长7年的持续葡萄糖监测(CGM)数据,比较HbA1c与基于CGM的更新版葡萄糖管理指标(uGMI)对新发糖尿病视网膜病变的预测性能。结果显示uGMI与视网膜病变的关联强于HbA1c(互信息分数0.148 vs 0.078),ROC曲线下面积略高(AUC 0.733 vs 0.704),联合二者未改善风险预测。

要点

  • uGMI对新发糖尿病视网膜病变的预测能力略优于HbA1c(AUC 0.733 vs 0.704)。
  • HbA1c与uGMI联合并未改善糖尿病视网膜病变的风险预测,二者不互补。
  • uGMI的预测优势在HbA1c 54 mmol/mol(7.1% NGSP)至58 mmol/mol(7.5% NGSP)区间更明显。

核心结论

  • uGMI较HbA1c对新发糖尿病视网膜病变风险仅有略强的预测能力,两者在预测视网膜病变风险上不具互补性。

研究设计与样本

  • 基于既往发表的纵向病例对照研究,收集1型糖尿病成人诊断新发糖尿病视网膜病变前最长7年的CGM数据,设无视网膜病变者为对照。
  • 采用互信息分数(MIS)、ROC曲线与机器学习模型评估视网膜病变与HbA1c、uGMI及CGM衍生指标的关联。

主要发现

  • uGMI与糖尿病视网膜病变的互信息分数为0.148,高于HbA1c的0.078。
  • ROC分析显示uGMI的AUC为0.733,HbA1c的AUC为0.704。
  • 同时纳入HbA1c与uGMI的决策树模型未改善临床显著糖尿病视网膜病变的风险预测。
  • 机器学习模型证实uGMI预测价值更好,尤其在HbA1c 54 mmol/mol(7.1% NGSP)至58 mmol/mol(7.5% NGSP)区间。
  • 在该HbA1c区间内糖尿病视网膜病变风险显著升高。

关键数值与推荐

  • uGMI的MIS为0.148,HbA1c的MIS为0.078。
  • uGMI的AUC为0.733,HbA1c的AUC为0.704。
  • 预测优势区间为HbA1c 54 mmol/mol(7.1% NGSP)至58 mmol/mol(7.5% NGSP)。

临床怎么用

  • 对1型糖尿病成人可考虑用基于CGM的uGMI辅助评估糖尿病视网膜病变风险。
  • HbA1c与uGMI联合使用并未提升视网膜病变风险预测,无需据此叠加两个指标。
  • 对HbA1c处于54–58 mmol/mol(7.1%–7.5% NGSP)区间的患者应关注视网膜病变风险升高。

局限性

  • 研究数据来自既往已发表的纵向病例对照研究,非前瞻性队列设计。
  • 研究仅针对1型糖尿病成人,结论外推至其他人群需谨慎。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS/HYPOTHESIS: This study aimed to compare the predictive performance of HbA1c and a continuous glucose monitoring (CGM)-based updated glucose management indicator (uGMI) in assessing incident diabetic retinopathy risk. METHODS: We used the data from a previously published longitudinal case-control study that collected CGM data for up to 7 years prior to diagnosis of incident diabetic retinopathy or no retinopathy (control participants) among adults with type 1 diabetes. Mutual information scores (MIS), receiver operating characteristics (ROC) curves and machine learning models were used to assess the associations of diabetic retinopathy with HbA1c, uGMI and CGM-derived metrics. RESULTS: The uGMI demonstrated a stronger association with incident diabetic retinopathy (MIS 0.148) compared with HbA1c (MIS 0.078). ROC analysis showed that uGMI had a modestly higher AUC (AUC 0.733) than HbA1c (AUC 0.704). Decision tree models incorporating both HbA1c and uGMI did not improve clinically significant diabetic retinopathy risk prediction. Machine learning models confirmed the better predictive value of uGMI, especially for HbA1c values between 54 mmol/mol (7.1% NGSP) and 58 mmol/mol (7.5% NGSP), where diabetic retinopathy risk escalated significantly. CONCLUSIONS/INTERPRETATION: The uGMI is a slightly stronger predictor of diabetic retinopathy risk compared with HbA1c. HbA1c and uGMI do not appear to be complementary for diabetic retinopathy risk prediction.

来源:Diabetologia,查看原文。版权归原作者所有。

引用

  1. Shah VN, Xu Y, Dabiri Y, et al. Association of HbA1c and an updated glucose management indicator (uGMI) with incident diabetic retinopathy in adults with type 1 diabetes: a longitudinal study. Diabetologia. 2025. PMID: 41217525. doi:10.1007/s00125-025-06599-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。